Showing results (1111-1120 of 1,129) with videos related to
Sort By:
Pageof 113
Best Practice & Research. Clinical Haematology|September 11, 2012
Advances in the management of venous thromboembolismSam SchulmanBest Practice & Research. Clinical Haematology|June 8, 2014
Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of careHarry J Iland, Andrew Wei, John F SeymourBest Practice & Research. Clinical Haematology|June 8, 2014
Can we say farewell to monitoring minimal residual disease in acute promyelocytic leukaemia?David Grimwade, Jelena V Jovanovic, Robert K HillsBest Practice & Research. Clinical Haematology|June 8, 2014
Extramedullary disease in APL: a real phenomenon to contend with or not?Chezi Ganzel, Dan DouerBest Practice & Research. Clinical Haematology|February 10, 2015
Mutational profiling in patients with MDS: ready for every-day use in the clinic?Ulrike Bacher, Alexander Kohlmann, Torsten HaferlachBest Practice & Research. Clinical Haematology|September 15, 2018
Peripheral T-cell lymphoma - are we making progress?Niloufer Khan, Neval Ozkaya, Alison Moskowitz, et al.Best Practice & Research. Clinical Haematology|July 23, 2025
Research progress of targeted BCMA CAR-T therapy for relapsed/refractory multiple myeloma antigen-negative relapseLulu Kong, Kailin Xu, Wei ChenBest Practice & Research. Clinical Haematology|July 23, 2025
Applications and prospects of molecularly targeted drugs combined with CAR-T cell therapy to treat multiple myelomaYan Xu, Jianping MaoBest Practice & Research. Clinical Haematology|July 23, 2025
Cytokines in transplantation toleranceAndre Souffrant, Avery Wilson, Bryar Hansen, et al.Best Practice & Research. Clinical Haematology|July 23, 2025
Tumor microenvironment in CAR-T cell therapy for lymphomaYuchen Zhu, Kailin Xu, Ying WangPageof 113